Meritage Portfolio Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,476
| Closed | -$72K | – | 342 |
|
|
2023
Q1 | $72K | Sell |
21,476
-738
| -3% | -$2.47K | 0.01% | 309 |
|
|
2022
Q4 | $107K | Buy |
22,214
+779
| +4% | +$3.75K | 0.01% | 306 |
|
|
2022
Q3 | $122K | Buy |
21,435
+76
| +0.4% | +$433 | 0.01% | 297 |
|
|
2022
Q2 | $152K | Buy |
21,359
+591
| +3% | +$4.21K | 0.01% | 299 |
|
|
2022
Q1 | $150K | Buy |
20,768
+2,635
| +15% | +$19K | 0.01% | 332 |
|
|
2021
Q4 | $162K | Buy |
+18,133
| New | +$162K | 0.01% | 331 |
|